EMA: Draft GL for OIPs [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2024-04-19 17:40 (355 d 16:17 ago) – Posting: # 23959
Views: 3,417

Dear all,

as a birthday gift the EMA published a

Draft guideline on the requirements for demonstrating therapeutic equivalence between orraly inhaled products (OIP) for asthma and chronic obstructive pulmonary disease (COPD).

Consultation is open until 30 October 2024.
—
Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,420 posts in 4,927 threads, 1,668 registered users;
31 visitors (2 registered, 29 guests [including 9 identified bots]).
Forum time: 09:58 CEST (Europe/Vienna)

To know the history of science is to recognize the mortality
of any claim to universal truth.    Evelyn Fox Keller

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5